stockrowPacific Biosciences of California, Inc. (PACB) vs QuidelOrtho Corporation (QDEL)
- Pacific Biosciences of California, Inc. PACB 2.29 −5.76%
- QuidelOrtho Corporation QDEL 11.06 −13.86%
Pacific Biosciences of California, Inc. and QuidelOrtho Corporation are both Medical Devices companies. QuidelOrtho Corporation is the larger, with a market value of $880.5M against $755.3M — 1.2× the size. Pacific Biosciences of California, Inc. grew revenue faster over the last twelve months: 4.41% against −4.47%. QuidelOrtho Corporation has the higher net margin (−14.2% vs −81.3%) and the lower return on invested capital (−1.75% vs 0.00%). Across the 17 metrics below, Pacific Biosciences of California, Inc. leads on 9 and QuidelOrtho Corporation on 8.
Valuation
Profitability
| Metric | PACB | QDEL | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.40% | 44.22% | 57.76% |
| Operating margin | (81.27%) | (4.91%) | (15.07%) |
| Net margin | (81.31%) | (14.24%) | (14.45%) |
| Free cash flow margin | (84.85%) | (4.55%) | (3.88%) |
| Return on equity | 1,037.83% | (19.29%) | (10.35%) |
| Return on assets | (17.22%) | (6.45%) | (17.26%) |
| Return on invested capital | 0.00% | (1.75%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack